Paxman AB (FRA:B0F) Debt-to-Equity : 0.11 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Paxman AB Debt-to-Equity?

Paxman AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.99 Mil. Paxman AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.23 Mil. Paxman AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €10.96 Mil. Paxman AB's debt to equity for the quarter that ended in Dec. 2023 was 0.11.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Paxman AB's Debt-to-Equity or its related term are showing as below:

FRA:B0F' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.08 Med: 0.15 Max: 4.43
Current: 0.11

During the past 7 years, the highest Debt-to-Equity Ratio of Paxman AB was 4.43. The lowest was 0.08. And the median was 0.15.

FRA:B0F's Debt-to-Equity is ranked better than
66.43% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FRA:B0F: 0.11

Paxman AB Debt-to-Equity Historical Data

The historical data trend for Paxman AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB Debt-to-Equity Chart

Paxman AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.11

4.43

0.14

0.15

0.11

Paxman AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.15	0.15	0.14	0.15	0.11

Competitive Comparison of Paxman AB's Debt-to-Equity

For the Medical Devices subindustry, Paxman AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paxman AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Paxman AB's Debt-to-Equity falls into.

Paxman AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Paxman AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.987	+	0.226)	/	10.962
	=	0.11

Paxman AB's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.987	+	0.226)	/	10.962
	=	0.11

Paxman AB (FRA:B0F) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Paxman AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Paxman AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Paxman AB (FRA:B0F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

PXMBF:USA PAX:Sweden

Address

Pirgatan 13, Karlshamn, SWE, SE-374 35

Website

https://www.paxman.se

Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines